Loading clinical trials...

COMPLETEDNA

A Study of the Effect of a Disease-Specific Migraine Smart Phone Application (App) on Participant Care

Impact of Integrating a Disease-Specific Migraine App Into the Management of Patients in the Primary Care Setting

NCT03559088•Eli Lilly and Company

View on ClinicalTrials.gov

Summary

The purpose of this study is to determine whether using a smart phone application to foster communication between study participants and their doctor will impact care. Participants must have a history of migraine or have recently been prescribed a common medicine to treat migraine. The study will last about one year for each participant.

Eligibility

Age

18 - 70 years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•Have a diagnosis of migraine (ICD10: G43.\*) since October 2015 OR a record of being prescribed a triptan prior to study
•Have not been prescribed a preventive migraine medication within the past twelve months
•Have not visited a neurologist in the past year
•Have an upcoming visit with their Atrium Health primary care provider

Exclusion Criteria

•Do not own an iOS or Android smart phone with a data plan or are unwilling to install the app on their phone
•Are currently participating in a clinical trial involving an investigational drug
•Have previously used the app used in this study
•Are pregnant at the time of study entry
•Are not able to provide informed consent
•Cannot speak and read English fluently

Locations (16)

Charlotte Internal Medicine

Charlotte, North Carolina, United States

Charlotte Medical Clinic

Charlotte, North Carolina, United States

Carmel Family Physicians

Charlotte, North Carolina, United States

Charlotte Medical Clinic-South Park

Charlotte, North Carolina, United States

Randolph Internal Medicine

Charlotte, North Carolina, United States

South Charlotte Primary Care

Charlotte, North Carolina, United States

Mecklenburg Medical Group - Ballantyne

Charlotte, North Carolina, United States

Table Rock Family Medicine

Glen Alpine, North Carolina, United States

Mecklenburg Medical Group - Northcross

Huntersville, North Carolina, United States

North Charlotte Medical Specialists - Huntersville

Huntersville, North Carolina, United States

Key Dates

Start Date

June 11, 2018

Primary Completion Date

April 26, 2019

Completion Date

April 26, 2019

Last Updated

July 22, 2020

Enrollment

120

ACTUAL participants

Conditions

Migraine

Interventions

Migraine App

OTHER

Sponsors

Lead Sponsor

Eli Lilly and Company

Collaborators

Wake Forest University Health Sciences

Related Studies

RECRUITINGPHASE3

A Study to Learn About the Study Medicine Called Rimegepant in Women When Used for Intermittent Prevention of Menstrual Migraine

NCT06641466

Menstrual Migraine

RECRUITINGPHASE3

A Clinical Trial to Evaluate Efficacy and Safety of Xeomin® Injections for Preventing Chronic Migraine

NCT07018713

Chronic Migraine

Mind Body Balance for Pediatric Migraine

NCT04715685

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: July 22, 2020Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions